ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TARA Protara Therapeutics Inc

1.935
-0.005 (-0.26%)
Last Updated: 16:40:18
Delayed by 15 minutes
Share Name Share Symbol Market Type
Protara Therapeutics Inc NASDAQ:TARA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.005 -0.26% 1.935 1.91 1.95 2.04 1.88 1.97 57,823 16:40:18

Additional Proxy Soliciting Materials (definitive) (defa14a)

27/04/2022 9:12pm

Edgar (US Regulatory)


 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Schedule 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No. )

 

Filed by the Registrant ☒

 

Filed by a party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material under § 240.14a-12

 

Protara Therapeutics, Inc.

 

(Name of Registrant as Specified In Its Charter)

 

N/A

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11

 

 

  

 

 

 

 

 

 

 

 

1 Year Protara Therapeutics Chart

1 Year Protara Therapeutics Chart

1 Month Protara Therapeutics Chart

1 Month Protara Therapeutics Chart

Your Recent History

Delayed Upgrade Clock